{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:35:52Z","timestamp":1770417352056,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clon.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T17:49:45Z","timestamp":1541699385000},"page":"e1-e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hypofractionated Concomitant Chemoradiation in Inoperable Locally Advanced Non-small Cell Lung Cancer: A Report on 100 Patients and a Systematic Review"],"prefix":"10.1016","volume":"31","author":[{"given":"M.S.","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Vashisht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"McMenemin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kovarik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mulvenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Greystoke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clon.2018.10.006_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"13","key":"10.1016\/j.clon.2018.10.006_bib2","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2018.10.006_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdj117","volume":"17","author":"Aup\u00e9rin","year":"2006","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clon.2018.10.006_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.radonc.2013.07.014","article-title":"Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centres","volume":"109","author":"Din","year":"2013","journal-title":"Radiother Oncol"},{"issue":"17","key":"10.1016\/j.clon.2018.10.006_bib5","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.ejca.2014.07.009","article-title":"SOCCAR: a randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III non-small cell lung cancer and good performance status","volume":"50","author":"Maguire","year":"2014","journal-title":"Eur J Cancer"},{"issue":"1062","key":"10.1016\/j.clon.2018.10.006_bib6","doi-asserted-by":"crossref","first-page":"20150966","DOI":"10.1259\/bjr.20150966","article-title":"Accelerated hypofractionated radiotherapy with concomitant chemotherapy in locally advanced squamous cell carcinoma of lung: evaluation of response, survival, toxicity and quality of life from a phase II randomized study","volume":"89","author":"Roy","year":"2016","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.clon.2018.10.006_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.radonc.2016.02.011","article-title":"Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab","volume":"118","author":"Walraven","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2018.10.006_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2013.10.009","article-title":"Additional weekly cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating","volume":"110","author":"van den Heuvel","year":"2014","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2018.10.006_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2006.09.005","article-title":"Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)","volume":"43","author":"Belderbos","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2018.10.006_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fonc.2013.00286","article-title":"Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer","volume":"3","author":"Donato","year":"2013","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.clon.2018.10.006_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.radonc.2013.08.017","article-title":"Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy","volume":"108","author":"Chen","year":"2013","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.clon.2018.10.006_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.clon.2011.05.006","article-title":"Toxicity of hypofractionated accelerated radiotherapy concurrent with chemotherapy for non-small cell carcinoma of the lung","volume":"23","author":"Carruthers","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2018.10.006_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1748-717X-2-27","article-title":"Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with non-small cell lung cancer","volume":"2","author":"Uitterhoeve","year":"2007","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clon.2018.10.006_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijrobp.2018.01.046","article-title":"Phase 1 study of accelerated hypofractionated radiation therapy with concurrent chemotherapy for stage III non-small cell lung cancer: CALGB 31102 (Alliance)","volume":"101","author":"Urbanic","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2018.10.006_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1748-717X-8-198","article-title":"High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy\/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study","volume":"8","author":"Liu","year":"2013","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clon.2018.10.006_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1748-717X-8-201","article-title":"Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy\/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial","volume":"8","author":"Lin","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2018.10.006_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/1471-2407-13-513","article-title":"Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen","volume":"13","author":"Bearz","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clon.2018.10.006_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cncr.24732","article-title":"Toxicity report of a phase 1\/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy","volume":"116","author":"Bral","year":"2010","journal-title":"Cancer"},{"issue":"2B","key":"10.1016\/j.clon.2018.10.006_bib19","first-page":"1349","article-title":"Hypofractionated\/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC)","volume":"28","author":"Tsoutsou","year":"2008","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.clon.2018.10.006_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cllc.2014.08.002","article-title":"Radical-intent hypofractionated radiotherapy for locally advanced non-small-cell lung cancer: a systematic review of the literature","volume":"16","author":"Kaster","year":"2015","journal-title":"Clin Lung Cancer"},{"issue":"20","key":"10.1016\/j.clon.2018.10.006_bib21","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655518304679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655518304679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:45:20Z","timestamp":1760543120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655518304679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0936655518304679"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2018.10.006","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypofractionated Concomitant Chemoradiation in Inoperable Locally Advanced Non-small Cell Lung Cancer: A Report on 100 Patients and a Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights reserved.","name":"copyright","label":"Copyright"}]}}